Viewing Study NCT02287233

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-02-24 @ 5:02 PM
Study NCT ID: NCT02287233
Status: COMPLETED
Last Update Posted: 2022-08-29
First Post: 2014-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None AML View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelogenous Leukemia View
None Treatment Naive AML View
None Untreated AML View